eduKateSG · Why Science?
Trace an ordered device from manufacturer to final recipient
Use FDA’s device-tracking rules through written orders, qualifying criteria, manufacturer methods, distributor duties, patient records, transfers, audits and safety action.
When a high-consequence device must be corrected quickly, knowing the product name is not enough. A useful tracking system can identify which specific device moved to which distributor, facility, professional or patient.
FDA’s medical-device tracking authority is implemented through 21 CFR part 821. Manufacturers adopt a tracking method after an FDA order for a device meeting the relevant criteria, and distributors help keep the route current.
Did you know? Device tracking and UDI are related but distinct. UDI standardizes identity; an FDA tracking order requires records that follow specified devices through distribution to the end user or patient.
This guide supports traceability and postmarket-safety literacy. It does not establish that a specific device is currently subject to a tracking order.
Chapter index
Chapters 1–9: tracking authority, device identity and distribution
- 1. Tracking is triggered by an FDA order
- 2. Failure risk can qualify a device
- 3. Long-term implants can qualify
- 4. Life-supporting devices outside facilities can qualify
- 5. Not every qualifying device is automatically tracked
- 6. The manufacturer establishes the method
- 7. Manufacturer records connect identity and location
- 8. Distributors pass information through the chain
- 9. Final distributors have patient-facing duties
Chapters 10–17: patient records, transfers, audits and response
- 10. Patient refusal is recorded
- 11. Transfers require updates
- 12. Audits test system effectiveness
- 13. Records must be available
- 14. Confidentiality remains important
- 15. UDI can support but does not replace tracking
- 16. Tracking supports recalls and notifications
- 17. A complete tracking receipt shows the whole route
Device tracking is designed for rapid location, notification and correction when certain devices create serious risk. Manufacturers implement 21 CFR part 821 tracking when FDA issues an order for a device that meets the statutory tracking criteria. This makes distribution evidence actionable during a safety response.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about tracking is triggered by an fda order? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for tracking is triggered by an fda order. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for tracking is triggered by an fda order, its identifier or version context, and one limit that must remain visible.
FDA may issue a tracking order for devices meeting statutory criteria. A device whose failure would be reasonably likely to have serious adverse health consequences can fall within the tracking authority. It also distinguishes ordered tracking from ordinary product traceability.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about failure risk can qualify a device? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for failure risk can qualify a device. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for failure risk can qualify a device, its identifier or version context, and one limit that must remain visible.
The manufacturer, distributor and final recipient each hold different pieces of the route. A device intended to be implanted in the human body for more than one year can meet a tracking criterion. Transfers and patient changes must remain current.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about long-term implants can qualify? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for long-term implants can qualify. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for long-term implants can qualify, its identifier or version context, and one limit that must remain visible.
CHAPTER 4 OF 17 · Read the order
4. Life-supporting devices outside facilities can qualify
A tracking record succeeds when it can answer where a device went and whom it affects. Life-sustaining or life-supporting devices used outside a device user facility can also meet the statutory criteria. The system is useful only if records can be produced accurately and promptly.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about life-supporting devices outside facilities can qualify? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for life-supporting devices outside facilities can qualify. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for life-supporting devices outside facilities can qualify, its identifier or version context, and one limit that must remain visible.
CHAPTER 5 OF 17 · Map the distribution chain
5. Not every qualifying device is automatically tracked
Device tracking is designed for rapid location, notification and correction when certain devices create serious risk. FDA uses discretion and issues written orders, so the current device-specific order is central. This makes distribution evidence actionable during a safety response.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about not every qualifying device is automatically tracked? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for not every qualifying device is automatically tracked. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for not every qualifying device is automatically tracked, its identifier or version context, and one limit that must remain visible.
CHAPTER 6 OF 17 · Map the distribution chain
6. The manufacturer establishes the method
FDA may issue a tracking order for devices meeting statutory criteria. The tracking system should enable the manufacturer to provide information required by the regulation throughout distribution. It also distinguishes ordered tracking from ordinary product traceability.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about the manufacturer establishes the method? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for the manufacturer establishes the method. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for the manufacturer establishes the method, its identifier or version context, and one limit that must remain visible.
CHAPTER 7 OF 17 · Map the distribution chain
7. Manufacturer records connect identity and location
The manufacturer, distributor and final recipient each hold different pieces of the route. Required fields can include device identity, lot or serial information, consignee, shipment and transfer details. Transfers and patient changes must remain current.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about manufacturer records connect identity and location? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for manufacturer records connect identity and location. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for manufacturer records connect identity and location, its identifier or version context, and one limit that must remain visible.
CHAPTER 8 OF 17 · Map the distribution chain
8. Distributors pass information through the chain
A tracking record succeeds when it can answer where a device went and whom it affects. Distributor records and reports help update the manufacturer as devices move to other distributors, facilities, health professionals or patients. The system is useful only if records can be produced accurately and promptly.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about distributors pass information through the chain? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for distributors pass information through the chain. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for distributors pass information through the chain, its identifier or version context, and one limit that must remain visible.
CHAPTER 9 OF 17 · Maintain the record
9. Final distributors have patient-facing duties
Device tracking is designed for rapid location, notification and correction when certain devices create serious risk. When applicable, final distributors collect and transmit patient and device information unless a recognized exemption applies. This makes distribution evidence actionable during a safety response.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about final distributors have patient-facing duties? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for final distributors have patient-facing duties. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for final distributors have patient-facing duties, its identifier or version context, and one limit that must remain visible.
FDA may issue a tracking order for devices meeting statutory criteria. The system accounts for a patient who declines to release identifying information while preserving the other required tracking record. It also distinguishes ordered tracking from ordinary product traceability.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about patient refusal is recorded? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for patient refusal is recorded. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for patient refusal is recorded, its identifier or version context, and one limit that must remain visible.
The manufacturer, distributor and final recipient each hold different pieces of the route. Sale, lease, donation, return, replacement, explantation, damage and permanent discontinuation can change the tracked status. Transfers and patient changes must remain current.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about transfers require updates? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for transfers require updates. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for transfers require updates, its identifier or version context, and one limit that must remain visible.
A tracking record succeeds when it can answer where a device went and whom it affects. Manufacturers perform periodic audits using a statistically relevant method and investigate discrepancies to show records can locate devices. The system is useful only if records can be produced accurately and promptly.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about audits test system effectiveness? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for audits test system effectiveness. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for audits test system effectiveness, its identifier or version context, and one limit that must remain visible.
Device tracking is designed for rapid location, notification and correction when certain devices create serious risk. FDA can request tracking information, and the system should retrieve accurate data within the regulatory timeframe. This makes distribution evidence actionable during a safety response.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about records must be available? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for records must be available. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for records must be available, its identifier or version context, and one limit that must remain visible.
FDA may issue a tracking order for devices meeting statutory criteria. Patient information is collected for safety tracking and must be handled within applicable legal and security requirements. It also distinguishes ordered tracking from ordinary product traceability.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about confidentiality remains important? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for confidentiality remains important. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. If a field is missing, write “not shown” and follow the official documentation rather than inventing a value.
Evidence checkpoint
Record the evidence object for confidentiality remains important, its identifier or version context, and one limit that must remain visible.
The manufacturer, distributor and final recipient each hold different pieces of the route. UDI improves device identity, while part 821 tracking follows ordered devices through the distribution chain to end users or patients. Transfers and patient changes must remain current.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about udi can support but does not replace tracking? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for udi can support but does not replace tracking. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Before comparing two records, check that their object types, methods, versions and units really align.
Evidence checkpoint
Record the evidence object for udi can support but does not replace tracking, its identifier or version context, and one limit that must remain visible.
A tracking record succeeds when it can answer where a device went and whom it affects. A reliable route helps locate affected devices and people when correction, removal or safety communication becomes necessary. The system is useful only if records can be produced accurately and promptly.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about tracking supports recalls and notifications? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for tracking supports recalls and notifications. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Finish by naming one supported statement and one stronger statement that still needs another evidence layer.
Evidence checkpoint
Record the evidence object for tracking supports recalls and notifications, its identifier or version context, and one limit that must remain visible.
CHAPTER 17 OF 17 · Test retrieval
17. A complete tracking receipt shows the whole route
Device tracking is designed for rapid location, notification and correction when certain devices create serious risk. Record the FDA order, device and identifier, manufacturer, initial consignee, distributors, shipment and receipt dates, final recipient, transfers, status changes, patient refusal, audits, discrepancies and retrieval tests. This makes distribution evidence actionable during a safety response.
Try this
Evidence question: Which official rule, guidance passage, label, report or record supports the point about a complete tracking receipt shows the whole route? Answer in three parts: identify the visible field or file, explain how it bears on the question, and state the boundary of that evidence. Preserve the database’s own object names and accession rather than flattening everything into the word ‘data’.
Try this: Record the device, identifier, version, date, result and one limit for a complete tracking receipt shows the whole route. Turn the result into a compact claim-evidence-reasoning note, then ask a partner to retrace it. Keep the identifier, retrieval date and source page in the note so the route can be repeated.
Evidence checkpoint
Record the evidence object for a complete tracking receipt shows the whole route, its identifier or version context, and one limit that must remain visible.
Contents · Previous chapter · Continue at the Science Learning Hub
A tracking system is proven when it can locate the right device quickly
Tracking records become safety infrastructure during recalls, notifications and corrections. The practical test is whether the route remains accurate after every transfer, return, explant or patient update.
Save the FDA tracking order and date, device name and model, UDI and serial or lot, manufacturer and sites, initial consignee, each distributor, shipment and receipt dates, final distributor, patient or end-user record where permitted, transfer and status changes, refusal or exemption documentation, audit design and results, discrepancies, corrections and FDA requests.
| Reading object | What it can support | Question to keep visible |
|---|---|---|
| Tracking order | Establishes the device-specific duty | Which criteria and effective date? |
| Distribution record | Follows device movement | Who received it and when? |
| Patient/end-user record | Connects final placement | Is consent or refusal recorded? |
| Audit result | Tests retrieval and accuracy | Which gaps were corrected? |
Sources and next reading
Substantive resource claims in this article were checked against the primary pages below. A structured record is a route into evidence; it does not by itself prove a scientific conclusion. Recheck the live record, evidence labels and release context before using it in assessed work or research.
For a classroom enquiry, save a short research receipt containing the question, search terms, selected object, exact identifier, version, access date and the evidence boundary you observed. Add the file or page that supports each statement. This small routine turns browsing into accountable science learning and gives a teacher, classmate or future analyst a route they can independently follow.
Before sharing the conclusion, ask another reader to retrace the route without verbal hints. If they reach a different version, file or interpretation, improve the receipt and narrow the claim. Reproducibility begins with this practical check. It teaches careful reading, supports fair collaboration and keeps uncertainty visible while evidence moves from an online service into notes, analysis and a final explanation.
A useful final review separates five questions. What object was found? Which organisation or repository maintains it? What exact evidence was inspected? Which statement does that evidence support? What remains uncertain? Answer each question in one sentence, then connect every answer to a visible field, file or source page. This review catches common mistakes: citing a collection when a file supplied the value, treating the newest release as the analysed release, confusing permission with scientific suitability, or turning a discovery count into a conclusion. It also gives students a calm way to improve work. A missing detail becomes a next research step instead of an invitation to guess. When the route is complete, the final explanation can stay simple because the identifiers, dates, versions, limitations and supporting evidence are already organised underneath it.
Primary sources
- FDA Medical Device Tracking — accessed 25 October 2026.
- FDA Medical Device Tracking Guidance — accessed 25 October 2026.
- 21 CFR Part 821 — accessed 25 October 2026.
- FDA Importing Medical Devices — accessed 25 October 2026.
- FDA QMSR Overview — accessed 25 October 2026.